Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pentosan polysulfate sodium 100mg capsules
0208020I0AAAGAG
|
Pentosan polysulfate sodium (Oral) | Pentosan polysulfate sodium | Cardiovascular System | 268 |
|
Elmiron 100mg capsules (Consilient Health)
0208020I0BEACAG
|
Elmiron | Pentosan polysulfate sodium | Cardiovascular System | 154 |
|
Elmiron 100mg capsules (Sovereign Medical)
0208020I0BEADAG
|
Elmiron | Pentosan polysulfate sodium | Cardiovascular System | 1 |
|
Elmiron 100mg capsules (Imported)
0208020I0BEABAG
|
Elmiron | Pentosan polysulfate sodium | Cardiovascular System | No data available |
|
Elmiron 100mg capsules (Teva)
0208020I0BEAAAG
|
Elmiron | Pentosan polysulfate sodium | Cardiovascular System | No data available |
|
Fibrase 50mg capsules
0208020I0BBAAAB
|
Fibrase (Oral) | Pentosan polysulfate sodium | Cardiovascular System | No data available |
|
Pentosan polysulfate sodium 50mg capsules
0208020I0AAABAB
|
Pentosan polysulfate sodium (Oral) | Pentosan polysulfate sodium | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.